deferoxamine

基本解释

Deferoxamine was used as an iron chelator.
去铁胺被用做铁的螯合剂。
Deferoxamine reduced brain atrophy and improved behavioral outcomes.
去铁胺能减轻脑萎缩，改善行为后果。
The two most common iron chelators used currently to manage iron overload problems are an injectable form, deferoxamine and oral form, deferiprone.
目前最常见的两种铁螯合剂分别是注射式的去铁敏的及口服式的去铁酮。
These include insulin, sulfonylurea medications for type 2 diabetes, corticosteroids, diuretics, birth control pills, deferoxamine, rifampin, terbutaline, and propranolol.
这些药品包括治疗二型糖尿病的胰岛素、磺尿类、皮质甾类、利尿剂、避孕药、双胍药、利福平、特普他林、心得安。
Objective: To evaluate the safety and efficacy of combining deferiprone(DFP)and deferoxamine(DFO)in iron chelation therapy in patients with thalassemia.
目的:探讨去铁酮(DFP)和去铁胺(DFO)联合用药对重症地中海贫血螯合治疗的安全性和有效性。